248 related articles for article (PubMed ID: 27566127)
1. Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer.
Wulaningsih W; Astuti Y; Matsuguchi T; Anggrandariyanny P; Watkins J;
Prostate; 2017 Jan; 77(1):22-32. PubMed ID: 27566127
[TBL] [Abstract][Full Text] [Related]
2. Serum folate and prostate-specific antigen in the United States.
Han YY; Song JY; Talbott EO
Cancer Causes Control; 2013 Aug; 24(8):1595-604. PubMed ID: 23702887
[TBL] [Abstract][Full Text] [Related]
3. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
4. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
5. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.
Peskoe SB; Joshu CE; Rohrmann S; McGlynn KA; Nyante SJ; Bradwin G; Dobs AS; Kanarek N; Nelson WG; Platz EA
Prostate; 2015 Aug; 75(11):1167-76. PubMed ID: 25919471
[TBL] [Abstract][Full Text] [Related]
6. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
[TBL] [Abstract][Full Text] [Related]
7. Obesity and prostate cancer detection: insights from three national surveys.
Parekh N; Lin Y; Dipaola RS; Marcella S; Lu-Yao G
Am J Med; 2010 Sep; 123(9):829-35. PubMed ID: 20800152
[TBL] [Abstract][Full Text] [Related]
8. Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey.
Flynn-Evans EE; Mucci L; Stevens RG; Lockley SW
J Natl Cancer Inst; 2013 Sep; 105(17):1292-7. PubMed ID: 23943864
[TBL] [Abstract][Full Text] [Related]
9. Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010.
Lacher DA; Hughes JP
Clin Chim Acta; 2015 Aug; 448():220-7. PubMed ID: 26093340
[TBL] [Abstract][Full Text] [Related]
10. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
11. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
12. The association between clinically determined periodontal disease and prostate-specific antigen concentration in men without prostate cancer: the 2009-2010 National Health and Nutrition Examination Survey.
Huang Y; Michaud DS; Lu J; Carter HB; Platz EA
Cancer Causes Control; 2019 Dec; 30(12):1293-1300. PubMed ID: 31637561
[TBL] [Abstract][Full Text] [Related]
13. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
Welch HG; Schwartz LM; Woloshin S
J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
[TBL] [Abstract][Full Text] [Related]
15. Less Than Ideal Cardiovascular Health Is Associated With Shorter Leukocyte Telomere Length: The National Health and Nutrition Examination Surveys, 1999-2002.
Gebreab SY; Manna ZG; Khan RJ; Riestra P; Xu R; Davis SK
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28154163
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
[TBL] [Abstract][Full Text] [Related]
17. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
[TBL] [Abstract][Full Text] [Related]
18. Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003-2006.
Loprinzi PD; Kohli M
Mayo Clin Proc; 2013 Jan; 88(1):11-21. PubMed ID: 23274016
[TBL] [Abstract][Full Text] [Related]
19. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
[TBL] [Abstract][Full Text] [Related]
20. Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.
Wang A; Lazo M; Carter HB; Groopman JD; Nelson WG; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1331-1338. PubMed ID: 31160348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
